Equity research of novo Nordisk - delivering value through sustainable growth
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Tipo de documento: | Dissertação |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10362/142088 |
Resumo: | In this project it is analyzed the pharmaceutical company Novo Nordisk A/S. For this purpose ,a deep and comprehensive study of its financial statements, balance sheet, pipeline, collaborations, taxes and cost of capital has been performed. The analysis undertaken has involved a comparison of Novo Nordisk A/S with its comparable peers within the pharmaceutical industry for a better acknowledgement of its current position in the market and its future development. The study of all the relevant fields at taining Novo Nordisk A/S share price and the inclusion of a sensitivity analysis, has allowed to get a reliable valuation of this stock. |
id |
RCAP_822764ca07352e631b34db6b5405e7a6 |
---|---|
oai_identifier_str |
oai:run.unl.pt:10362/142088 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Equity research of novo Nordisk - delivering value through sustainable growthValuationForecastingHealthFinanceEquity researchInsulinPharmaceutical industryPatentsObesityPipelinePharmaceuticalsDomínio/Área Científica::Ciências Sociais::Economia e GestãoIn this project it is analyzed the pharmaceutical company Novo Nordisk A/S. For this purpose ,a deep and comprehensive study of its financial statements, balance sheet, pipeline, collaborations, taxes and cost of capital has been performed. The analysis undertaken has involved a comparison of Novo Nordisk A/S with its comparable peers within the pharmaceutical industry for a better acknowledgement of its current position in the market and its future development. The study of all the relevant fields at taining Novo Nordisk A/S share price and the inclusion of a sensitivity analysis, has allowed to get a reliable valuation of this stock.Filipe, João Miguel Gonçalves do CarmoRUNMoreno, César Cervantes2022-07-19T10:11:53Z2022-01-132021-12-172022-01-13T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttp://hdl.handle.net/10362/142088TID:202997561enginfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-03-11T05:19:27Zoai:run.unl.pt:10362/142088Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:50:08.074981Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Equity research of novo Nordisk - delivering value through sustainable growth |
title |
Equity research of novo Nordisk - delivering value through sustainable growth |
spellingShingle |
Equity research of novo Nordisk - delivering value through sustainable growth Moreno, César Cervantes Valuation Forecasting Health Finance Equity research Insulin Pharmaceutical industry Patents Obesity Pipeline Pharmaceuticals Domínio/Área Científica::Ciências Sociais::Economia e Gestão |
title_short |
Equity research of novo Nordisk - delivering value through sustainable growth |
title_full |
Equity research of novo Nordisk - delivering value through sustainable growth |
title_fullStr |
Equity research of novo Nordisk - delivering value through sustainable growth |
title_full_unstemmed |
Equity research of novo Nordisk - delivering value through sustainable growth |
title_sort |
Equity research of novo Nordisk - delivering value through sustainable growth |
author |
Moreno, César Cervantes |
author_facet |
Moreno, César Cervantes |
author_role |
author |
dc.contributor.none.fl_str_mv |
Filipe, João Miguel Gonçalves do Carmo RUN |
dc.contributor.author.fl_str_mv |
Moreno, César Cervantes |
dc.subject.por.fl_str_mv |
Valuation Forecasting Health Finance Equity research Insulin Pharmaceutical industry Patents Obesity Pipeline Pharmaceuticals Domínio/Área Científica::Ciências Sociais::Economia e Gestão |
topic |
Valuation Forecasting Health Finance Equity research Insulin Pharmaceutical industry Patents Obesity Pipeline Pharmaceuticals Domínio/Área Científica::Ciências Sociais::Economia e Gestão |
description |
In this project it is analyzed the pharmaceutical company Novo Nordisk A/S. For this purpose ,a deep and comprehensive study of its financial statements, balance sheet, pipeline, collaborations, taxes and cost of capital has been performed. The analysis undertaken has involved a comparison of Novo Nordisk A/S with its comparable peers within the pharmaceutical industry for a better acknowledgement of its current position in the market and its future development. The study of all the relevant fields at taining Novo Nordisk A/S share price and the inclusion of a sensitivity analysis, has allowed to get a reliable valuation of this stock. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-12-17 2022-07-19T10:11:53Z 2022-01-13 2022-01-13T00:00:00Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/masterThesis |
format |
masterThesis |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10362/142088 TID:202997561 |
url |
http://hdl.handle.net/10362/142088 |
identifier_str_mv |
TID:202997561 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799138098740723712 |